Gene Expression Analysis Market worth $5.93 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., April 15, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 to USD 5.93 billion by 2031, at a CAGR of 7.0%.

Browse 430 market data Tables and 50 Figures spread through 450 Pages and in-depth TOC on 'Gene Expression Analysis Market - Global Forecast to 2031'

Gene Expression Analysis Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 4.23 billion
• 2031 Projected Market Size: USD 5.93 billion
• CAGR (2026–2031): 7.0%

Gene Expression Analysis Market Trends & Insights:

• By application, the drug discovery & development segment accounted for the largest share of the gene expression analysis market in 2025. This is attributed to the extensive use of gene expression profiling in target identification, biomarker discovery, and validation processes, which enhances the efficiency and success rate of drug development pipelines.
• North America accounted for the largest share of the gene expression analysis market in 2025. The growth in this region is driven by strong genomics research activities, advanced healthcare and research infrastructure, high investments in biotechnology, supportive regulatory frameworks, and the presence of leading market players promoting the adoption of advanced gene expression technologies.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968

The gene expression analysis market is expanding as pharmaceutical companies, biotechnology firms, and academic research centers increasingly adopt solutions to advance molecular research and disease understanding. These solutions support applications such as gene profiling, biomarker identification, and therapeutic response analysis. The growing focus on precision medicine and targeted treatments is further driving the demand for gene expression insights across research and clinical environments. Advancements in data analysis, workflow integration, and result interpretation are improving reproducibility and enabling more informed decision-making. Together, these developments support more efficient research processes and contribute to faster and more reliable development of targeted.

North America commanded the largest share of the gene expression analysis market in 2025. This region is driving market growth due to the presence of advanced research infrastructure and significant investments in genomics and molecular biology programs. It leads in large-scale gene expression studies, biomarker research, and precision medicine initiatives. Key players in the region include Thermo Fisher Scientific, Illumina, Revvity, and Bio-Rad Laboratories, which provide strong capabilities in gene analysis workflows and data interpretation. These companies contribute significantly to making North America a key hub for innovation, early-stage research, and adoption of advanced gene expression analysis solutions.

By offering, the reagents & consumables segment held the largest share of the gene expression analysis market in 2025.

the gene expression analysis market is segmented into reagents & consumables, Instruments, and Services. In 2025, reagents & consumables accounted for the largest market share. This is primarily attributed to their recurring usage across gene expression workflows, leading to consistent demand from research laboratories and clinical settings. The growing volume of gene expression studies, coupled with increased research activities in areas such as oncology and genetic disorders, has further driven the consumption of these products. Additionally, the need for high-quality and reliable reagents to ensure accuracy and reproducibility in results contributes to the dominance of this segment.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=156613968

By application, the drug discovery & development segment held the largest share of the gene expression analysis market in 2025.

the gene expression analysis market is segmented into drug discovery & development, clinical diagnostics, and other applications. In 2025, drug discovery & development accounted for the largest market share. This is due to the increasing reliance on gene expression insights to identify potential drug targets, understand disease mechanisms, and evaluate therapeutic responses. The expanding pipeline of novel therapeutics, particularly in oncology and rare diseases, has significantly increased the adoption of gene expression analysis in early-stage research and development. Furthermore, the growing focus on precision medicine and biomarker-based drug development continues to strengthen the position of this segment in the market.

North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the gene expression analysis market. This is supported by a strong pharmaceutical and biotechnology base, along with rapid adoption of advanced molecular research approaches. The US leads in research funding, innovation, and regulatory support for genomic studies. The presence of leading research institutes, clinical laboratories, and major life sciences companies drives demand for gene expression analysis across various applications. Ongoing research programs, consistent funding, and strong collaboration between industry and academia further support market growth in North America.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=156613968

Top Companies in Gene Expression Analysis Market:

The Top Companies in Gene Expression Analysis Market include Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Revvity (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Bruker (US), and Bio-Rad Laboratories, Inc. (US), among others.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Related Reports:

Genomics Market - Global Forecast to 2030

Next-generation Sequencing Market - Global Forecast to 2031

PCR Technologies Market - Global Forecast to 2030

Gene Editing Market - Global Forecast to 2029

CRISPR Market - Global Forecast to 2030

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets